Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiencyGut microbiota: next frontier in understanding human health and development of biotherapeuticsClinical use of crizotinib for the treatment of non-small cell lung cancerDenileukin diftitox for the treatment of cutaneous T-cell lymphomaSafety and efficacy of enzyme replacement therapy in the nephropathy of Fabry diseaseEGFR targeted therapy in non-small cell lung cancer: potential role of cetuximabReview of interferon beta-1b in the treatment of early and relapsing multiple sclerosisNew targeted treatments for non-small-cell lung cancer - role of nivolumabSelective biologics for ulcerative colitis and Crohn's disease - clinical utility of vedolizumabUpdate on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinibBiosimilars in the management of neutropenia: focus on filgrastimEmerging treatments in Castleman disease - a critical appraisal of siltuximabLipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patientsAdvanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitorsRole of collagenase clostridium histolyticum in Peyronie's diseaseClinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemiaClinical utility of ramucirumab in advanced gastric cancerLocalization and upregulation of survivin in cancer health disparities: a clinical perspectiveGiant-cell tumor of bone: treatment options and role of denosumabMultikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinibOptimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of actionMonoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitorsEmerging treatments and combinations in the management of NSCLC: clinical potential of nintedanibNeutralizing activities of human immunoglobulin derived from donors in Japan against mosquito-borne flaviviruses, Japanese encephalitis virus, West Nile virus, and dengue virusResistant mutations in CML and Ph(+)ALL - role of ponatinib.Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosisEag1 channels as potential early-stage biomarkers of hepatocellular carcinomaUpdate on sepsis-associated acute kidney injury: emerging targeted therapiesCentrosome - a promising anti-cancer targetThe role of epigenetic mechanisms and processes in autoimmune disordersEverolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenibMethods, potentials, and limitations of gene delivery to regenerate central nervous system cellsSafety and efficacy of enzyme replacement therapy in the nephropathy of Fabry diseaseUse of human protein C concentrates in the treatment of patients with severe congenital protein C deficiencyImmunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virusSafety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma.Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus.Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulinSafety of biologics in rheumatoid arthritis: data from randomized controlled trials and registries.Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat.
P1433
Q24612253-653B0C1E-96A9-444E-B2CE-F09BF31797F1Q24617327-7A9185FE-34CF-4B98-BF17-4FEC8C0EF0B5Q24630466-F6807612-F43B-4A53-81CD-CC18A22C9E25Q24650893-8FB3FCD7-2317-4278-8D2A-6B14878B6214Q24650910-948C1FF2-9689-4C9C-8382-EF2057A6CCBDQ24652337-B892A108-75CB-4BBC-BBAB-BF806B3B58AEQ24652353-07B8585C-C71B-4FCC-81E9-0943F750D700Q26740988-8B61DBC4-CC82-4B34-8DD6-937436C8B096Q26750456-97445316-7EAB-4B8A-97EA-21B4356B4D26Q26751285-0622ABC7-46F7-499E-9724-C91D582BEAA7Q26764906-C7C058A4-9884-499A-82A2-6E51201D3884Q26766554-DC4F9FD3-C200-4311-81A1-9611A7EAD373Q26768126-457E209A-DDFB-4AF8-85AF-67CE1E9AD75FQ26775917-75B84981-AA17-4803-A6DA-923D4977C791Q26778518-208EA175-040F-43BC-B48C-509E20AC1F4DQ26783600-06992CEB-24A8-46DD-A902-87B77666E47CQ26785665-95861FDF-1A0F-4B2A-9EAB-14ED2488428EQ26799719-1DCECC92-DFCE-4561-BC70-F71D6891A78CQ26800332-B8804D74-8D66-4373-9173-80FB52F2827DQ26821959-32560F12-203A-4CFB-AE42-F691933E6623Q26822611-6B7C2063-2DC3-47D5-BEBE-26F4EA6844ABQ26824970-0A7FFED0-DAB7-4C6C-9710-32394F50FB9AQ26995204-5F79C952-578B-4D1D-ADE3-3DC5750F9834Q27468955-C991475A-9BB9-4E6A-9293-6539A78ED33DQ27853085-C99E5667-2EAA-4BCD-895E-788CCBC6F5D7Q28066677-79571B52-0784-4569-96EE-99BE80929CBAQ28069313-375EA7E9-D5FB-4E89-9E7B-FB49A098EF36Q28074631-84A2C75D-8EEC-4FCB-B17F-691450C47B79Q28077520-53DD29AD-81C7-4291-B863-FF3964734E76Q28389137-3CA3BF95-2844-4425-ADA9-55F47AADF4C3Q28765488-B7A18F99-651A-4172-B534-7660866BFD0CQ28766660-E1AD1998-8F1F-401D-9A87-157F09984D19Q29304569-74A213F4-DBEB-4F8A-A01A-3ED956C41C19Q29540563-079B9107-D694-403A-9962-49109E084902Q30355629-D36B4AD0-CFBB-482E-8C14-7C96651F9DA9Q30380999-636DBC5D-3FCC-48C3-95A2-3665D240C549Q30393251-55E81894-5F0A-4310-8331-8944E17F7F8AQ30400215-DFE9F969-D72D-4F0A-B00C-78FB5BA96602Q30891297-EDACE9C9-356B-400C-8387-46C18C7EB84FQ33385966-19A1099E-45FD-4448-95DD-99FAEDB85C3D
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Dove Medical Press
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
Biologics: Targets and Therapy
@ast
Biologics: Targets and Therapy
@en
Biologics: Targets and Therapy
@es
Biologics: Targets and Therapy
@it
Biologics: Targets and Therapy
@nl
type
label
Biologics: Targets and Therapy
@ast
Biologics: Targets and Therapy
@en
Biologics: Targets and Therapy
@es
Biologics: Targets and Therapy
@it
Biologics: Targets and Therapy
@nl
altLabel
Biologics : Targets & Therapy
@en
prefLabel
Biologics: Targets and Therapy
@ast
Biologics: Targets and Therapy
@en
Biologics: Targets and Therapy
@es
Biologics: Targets and Therapy
@it
Biologics: Targets and Therapy
@nl
P31
P243
P1055
P1058
P1156
17600155056
P1160
Biol. Targets Ther.
P1277
P1476
Biologics
@en
P1680
Targets and Therapy
@en
P236
P243
P407
P5115
P571
2007-01-01T00:00:00Z